Trial NCT03797066

View at ClinicalTrials.gov 
Org. Study IDs: KCHATTIC01

Last trial update was posted on 2023-05-06

MeSH Interventions

Elbasvir-grazoprevir drug combination

MeSH Conditions

Hepatitis Hepatitis A Hepatitis C Hepatitis C, Chronic

Other Conditions


Stopping Reasons

Changing parameters in HCV management, resulted in poor recruitment; additionally onset of SARS CoV2 resulted in the cessation of all mobile clinical services.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID